The precision of brachytherapy starts with millimeter-level spatial positioning. Tumor lesions vary greatly in location within the human body: some lie deep in the pelvic cavity, some attach to the chest wall, while others develop superficially under the skin. Patients also present with a wide range of body types, from slim individuals to severely obese patients. As a result, the one-size-fits-all approach is completely inapplicable to brachytherapy.

The length and gauge of brachytherapy needles are the two core physical parameters that determine whether the devices can reach target lesions safely and accurately and deliver treatment efficiently. Professional manufacturers of brachytherapy needles act as anatomy-savvy engineers. By developing a scientific, complete and graded specification portfolio, they enable the instruments to precisely adapt to complex human anatomical structures and individualized treatment plans.

1. Strategic Length Range: Full Coverage from Superficial Tissues to Deep Target Lesions

The working length of a brachytherapy needle, namely the effective puncture depth from the tip to the fixation point, defines its reach. Manufacturers provide a continuous or segmented selection of lengths, ranging from ultra-short needles of several centimeters to extra-long ones over 20 centimeters.

• Short needles (5–10 cm): Designed for superficial tumors, including certain skin cancers, superficial lesions in the head and neck region, and boost irradiation for tumor beds after breast cancer surgery. Featuring flexible manipulation, intuitive puncture paths and easy fixation, these needles allow rapid and accurate placement.
• Standard-length needles: The most widely used mainstream models for most tumors in the pelvic cavity and mid-abdomen, such as cervical cancer, prostate cancer via the perineal approach and some rectal cancers. They strike an optimal balance between rigidity and maneuverability.
• Extended-length needles (≥ 15 cm): Indispensable for obese patients and deep-seated lesions, such as intrahepatic metastases and deep retroperitoneal tumors. Sufficient length is a prerequisite for the needle tip to penetrate thick subcutaneous and peritoneal fat layers and accurately reach deep targets. Extended needles are generally engineered with higher rigidity to prevent deflection, and their puncture depth is subject to stricter control requirements.

2. Delicate Gauge Selection: Optimization Among Lumen Patency, Structural Strength and Minimal Invasiveness

Needle outer diameter is marked by Gauge (G), where a higher figure indicates a thinner shaft. Brachytherapy needles commonly range from 14G (thicker) to 21G (ultra-thin).

• Large gauges (14G–16G): They feature wide lumens and high rigidity. The spacious inner channel allows smooth passage of radioactive seeds, especially permanent seeds with a certain diameter, effectively preventing jamming. Robust rigidity keeps the shaft straight during penetration through dense tissues such as the prostate and fibrotic tumors, or during long-distance insertion. A linear puncture path is critical to achieving the planned dose distribution. Nevertheless, larger gauges cause relatively greater instantaneous tissue trauma.
• Small gauges (17G–21G): Their core advantage is superior minimal invasiveness. Thinner shafts markedly reduce tissue damage, bleeding and postoperative pain, making them ideal for cases requiring multi-needle implantation, soft tissue tumors and patients with heightened pain sensitivity. Modern manufacturing techniques ensure adequate puncture rigidity even for fine needles. However, their narrow lumens impose higher requirements on the dimensional consistency of seeds and the precision of delivery systems.

3. Systematic Compatibility with Treatment Plans and Auxiliary Systems

Dimensional design is not standalone. Brachytherapy needles must be fully compatible with algorithm models of Treatment Planning Systems (TPS), imaging guidance equipment including ultrasound puncture brackets and CT-compatible accessories, as well as seed delivery devices.

For instance, TPS calculates dose distribution based on needle arrangement and spacing, while needle diameter and material will affect dose computation such as attenuation correction. Professional manufacturers not only offer a full range of specifications, but also provide detailed compatibility lists and clinical data-based selection guidelines. These resources assist radiation physicists and clinicians in choosing the most appropriate devices according to specific treatment plans, patient anatomy and in-hospital equipment. This enables accurate implementation of the designed dose distribution and realizes seamless transition from treatment planning to clinical execution.